Bloom MD review
Priced weight loss, silent peptides
A Utah telehealth storefront with one of the most itemised GLP-1 price ladders we track — and no published price at all for its sermorelin, NAD⁺ or glutathione.
Our verdict
Bloom MD proves it can publish detailed pricing when it wants to: its weight-loss catalogue is itemised down to the dose, plan length and format. None of that discipline reaches the peptide line, which is listed and left unpriced. For a peptide shopper that is the wrong half of the catalogue to be transparent about, and there is a membership structure on the same site worth reading twice before you buy anything.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- Peptide telehealth
- Access
- Free consultation; NAD⁺ pricing not published
- Visit
- Video visit
- Updated
- July 2026
Popular alternative
Oak Longevity
Low-cost sermorelin within a broader longevity stack
Check Oak Longevity availability →What it is
Bloom MD is a direct-to-consumer telehealth storefront covering weight loss, longevity and wellness, with a stated contact number in Utah. Its longevity and wellness line includes sermorelin, NAD⁺ and glutathione. Its weight-loss catalogue is far more developed: compounded semaglutide on a flat any-dose plan, compounded tirzepatide priced up a published dose ladder, liraglutide, a tirzepatide microdose option, oral GLP-1 drops, and membership programs attached to oral pill options. A free consultation is offered site-wide.
How it works
Book a free consultation, a licensed clinician reviews your information, and product ships — a storefront model rather than a clinical relationship, and the catalogue is structured accordingly, with subscriptions, fixed-term programs and starter plans sitting side by side. Two things are worth reading carefully before you buy. First, the pill memberships advertised at $75/mo are a membership fee that explicitly does not include the cost of the medication, which is a structure that can be misread as a price. Second, free shipping is conditional on an order threshold rather than unconditional. The company publishes no state list, names no compounding pharmacy, names no medical director, and includes no baseline lab work — so before a growth-hormone-axis peptide there is no workup in the default path, and no way to confirm coverage without going through the consultation.
Pricing transparency
No sermorelin, NAD⁺ or glutathione price is published, so we are not quoting one for this board. What Bloom MD does publish is unusually granular on the weight-loss side — a flat any-dose monthly plan and a 90-day option for compounded semaglutide, a per-dose ladder for compounded tirzepatide that climbs meaningfully as you titrate, plus liraglutide, microdose and oral-drop options each with their own figure. That granularity is genuinely useful, and it is also the reason the silence on the peptide line stands out. Ask for the monthly peptide price, whether it scales with dose the way the tirzepatide ladder does, whether shipping clears the free-shipping threshold, and confirm that any "membership" quote actually includes the medication.
Branded vs compounded
Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. The peptide and GLP-1 products are compounding-pharmacy preparations, not therapeutically equivalent to branded drugs, and no compounding pharmacy is named anywhere. On the evidence, the wellness line splits cleanly into three. Sermorelin acts on the growth-hormone axis, a real and well-described mechanism with thin long-term human outcome data and no controlled trial behind the recovery or body-composition claims made for it. Injectable NAD⁺ has no controlled human outcome trials; the oral precursors NR and NMN are the forms with human data, and what they establish is a raised blood NAD⁺ level rather than a clinical benefit. Injectable glutathione has essentially no controlled human outcome evidence for the wellness and skin claims attached to it. One more note that belongs here: the microdose GLP-1 option on the same catalogue uses sub-therapeutic dosing, which has a thinner trial base than full-dose therapy and should be expected to do less. Individual results vary.
Pros and watch-outs
What we like
- One of the most itemised GLP-1 price ladders we track, published rather than gated
- Free consultation offered site-wide before any purchase
- A wellness line that includes sermorelin, NAD⁺ and glutathione alongside weight loss
- Multiple formats — injection, microdose and oral drops — priced individually
- A published Utah phone number rather than a contact form only
Watch-outs
- No published price for sermorelin, NAD⁺ or glutathione
- The $75/mo pill memberships are a fee that explicitly excludes the medication cost
- Free shipping is conditional on an order threshold, not unconditional
- No state list, no named compounding pharmacy and no named medical director
- Compounded tirzepatide pricing climbs with dose, so the entry figure is not the ongoing one
Best for
People who want a peptide alongside a fully itemised weight-loss catalogue and are willing to ask for the peptide price separately.
Who should look elsewhere
Anyone comparing peptide costs before booking, or who wants a named pharmacy, published state coverage or baseline labs.
The evidence behind what Bloom MD prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
How Bloom MD compares
A few alternatives worth a look, depending on what you’re optimizing for.
AgelessRxSermorelin from a longevity-medicine practice
See AgelessRx →- Luvo Health
Prescription NAD⁺ as an injection, drops or nasal spray at one flat price
See Luvo Health → 
EdenSermorelin in an oral fast-dissolve (ODT) alternative to injections
See Eden →
Pharmacology & mechanisms · Reviewed and last verified July 2026
How we assessed this. This review reflects Aminoscope’s own read of Bloom MD’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What does Bloom MD charge for sermorelin or NAD⁺?
- It does not publish a figure, so we are not quoting one. Only the weight-loss catalogue is priced publicly. Ask for the monthly peptide price, whether it scales with dose the way its tirzepatide ladder does, and what shipping adds.
- What is the $75/mo membership?
- It is a membership fee for the oral pill programs, and the site states plainly that it does not include the cost of the medication. It is easy to misread as a treatment price, so if you are quoted a membership figure, confirm separately what the medication itself will cost each month.
- Which states does Bloom MD serve?
- It does not publish a list. Its stated contact number is in Utah, but coverage is only confirmed during the free consultation. Its compounding pharmacy is not named either, so ask both questions at the same time.
- Is the microdose GLP-1 option as effective as full dosing?
- It should not be expected to be. Sub-therapeutic dosing has a much thinner trial base than the full doses used in the pivotal trials, and a smaller expected effect. Treat it as a cost-and-tolerability choice, not an equivalent protocol.